FDA Inspection
Boehringer Ingelheim Pharmaceuticals, Inc.FDA Inspection 1281125 - Boehringer Ingelheim Pharmaceuticals, Inc. - September 11, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on September 11, 2025, issued by the New England District Office, covering human drugs.
- Inspection Date
- September 11, 2025
- Product Type
- Human Drugs
Open in Dashboard
ID · 9c62d459-d5fc-4614-8d41-987968509962
Violation Codes1
21 CFR 312.50
Full citation text and observation details available on the Dashboard.